First systemic evidence for safety of tPA in stroke patients with sickle cell disease
Adult patients with sickle cell disease (SCD) who experience a stroke caused by a clot (i.e., ischemic strokes or IS) can be treated safely with tissue plasminogen activator (tPA) if they qualify, report investigators at ...
Apr 11, 2017
0
14